ZAMPER
LIVE

Serial Number

79379076

Owner

Rapigen INC.

Attorney

James C. Watson

Filing Date

Jul 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ZAMPER Trademark

Serial Number: 79379076 • Registration: 7636728

ZAMPER is a trademark filed by Rapigen INC. on July 28, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Rapigen INC. (3 trademarks)

3F, 4F, 16, LS-ro 91beon-gil, Dongan-gu,

Entity Type: 03

Trademark Details

Filing Date

July 28, 2023

Registration Date

January 7, 2025

Published for Opposition

November 19, 2024

Goods & Services

In vitro diagnostic preparations for medical purposes; reagents for use in medical genetic testing; clinical diagnostic reagents for medical or veterinary purposes; chemical preparations for pharmaceutical or medical purposes, namely, for DNA analysis; biological indicators for medical diagnosis for medical or veterinary purposes; medical diagnostic molecular analytes being diagnostic agents for detection and verification of infectious diseases; medical diagnostic test strips for blood analysis, urine analysis, saliva analysis

In vitro diagnostic reagents for scientific purposes; diagnostic reagents for scientific or research use; diagnostic preparations for scientific or research use; reagent, namely, polymerase RNA and DNA formulations for nucleic acid amplifications for scientific or laboratory purposes; chemical reagents for genetic identity testing; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis, or labeling of nucleic acid for scientific or laboratory purposes; reagents for use in scientific apparatus for chemical or biological analysis

In vitro diagnostic devices being incubators, ultrasound apparatus, cytometers, hematology analyzers, sample preparation devices, apparatus for testing DNA and RNA samples for medical purposes; genetic testing apparatus for medical purposes, namely, real-time gene amplification equipment for medical use; genetic testing apparatus for medical purposes; genetic testing apparatus for medical purposes being miniaturized sensors for use in gene analysis and diagnosis; genetic testing apparatus for medical purposes and apparatus for DNA and RNA testing for medical purposes; diagnostic apparatus for medical purposes used in medical laboratories for testing blood sugar levels, cancer cells, DNA; blood pressure and diabetic diagnostic medical devices; blood containers for medical purposes, sold empty

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 26, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 6, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 6, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 7, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 8, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 20, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 20, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 9, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 9, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 9, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 9, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2024 TROA
REFUSAL PROCESSED BY IB
May 8, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 17, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 17, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 31, 2024 RFCR
NON-FINAL ACTION WRITTEN
Mar 30, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 26, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 21, 2023 REPR